Exchange: NASDAQ·Updated 07:30 PM EDT

ULBI News

News
all
press releases
Ultralife Upgraded to Neutral on Backlog & Product Commercialization
ULBI's upgrade to Neutral reflects record backlog, product commercialization, manufacturing improvements and broader opportunities from vertical integration.
Zacks
Ultralife Upgraded to Neutral on Backlog & Product Commercialization
ULBI's upgrade to Neutral reflects record backlog, product commercialization, manufacturing improvements and broader opportunities from vertical integration.
Zacks
More News
Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip
ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.
Zacks
Zacks Initiates Coverage of Ultralife With Underperform Recommendation
Discover why Zacks rates Ultralife as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore ULBI's struggles with execution risks, margin pressure and commercialization delays that could delay its earnings recovery.
Zacks
Ultralife (ULBI) Q1 2026 Earnings Transcript
Ultralife (ULBI) Q1 2026 Earnings Transcript...
Yahoo! Finance: News
Ultralife (ULBI) Expected to Announce Quarterly Earnings on Thursday
Ultralife (NASDAQ:ULBI) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...
MarketBeat
Ultralife (NASDAQ:ULBI) Stock Price Crosses Above 200-Day Moving Average - What's Next?
Ultralife (NASDAQ:ULBI) Stock Crosses Above Two Hundred Day Moving Average - Here's Why...
MarketBeat
Ultralife (NASDAQ:ULBI) Share Price Crosses Above 200-Day Moving Average - Here's What Happened
Ultralife (NASDAQ:ULBI) Stock Price Crosses Above 200 Day Moving Average - Here's Why...
MarketBeat
Ultralife (NASDAQ:ULBI) Share Price Passes Above 200-Day Moving Average - What's Next?
Ultralife (NASDAQ:ULBI) Stock Passes Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat
Ultralife (NASDAQ:ULBI) Shares Cross Above Two Hundred Day Moving Average - What's Next?
Ultralife (NASDAQ:ULBI) Stock Crosses Above 200 Day Moving Average - Should You Sell...
MarketBeat
Ultralife (NASDAQ:ULBI) Share Price Crosses Above 200 Day Moving Average - Time to Sell?
Ultralife (NASDAQ:ULBI) Share Price Crosses Above 200 Day Moving Average - What's Next...
MarketBeat

Advertisement|Remove ads.